Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics - A Global Market Overview" report has been ...

界面新闻记者 | 黄华界面新闻编辑 | 谢欣10月8日，渤健（Biogen）旗下的托夫生注射液（商品名：凯盛迪）在国内获批，成为中国首个获批用于携带超氧化物歧化酶1（SOD1）基因突变的肌萎缩侧索硬化（ALS）成人患者的疾病修正治疗药物。肌萎缩侧索硬化（Amyotrophic Lateral ...

Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...

Oblimersen sodium (Genasense™) is an antisense oligodeoxynucleotide specific for the antiapoptotic protein Bcl-2, which could enhance the sensitivity of leukemic cells to chemotherapy in this ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

10 月 7 日，瑞典卡罗琳斯卡医学院宣布，2024 年诺贝尔生理学或医学奖授予美国科学家 Victor Ambros 和 Gary Ruvkun 以表彰他们发现了 microRNA (miRNA，微小 RNA) 及其在基因调控中的作用。

Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...

Researchers have used microcellular "drones" to deliver antisense oligonucleotide therapeutics to lung cancer cells.